Benzinga | Aug 5, 2020 04:16PM EDT

Vanda Pharmaceuticals Q2 EPS $0.16 Down From $0.21 YoY, Sales $62.20M Beat $61.95M Estimate

Vanda Pharmaceuticals (NASDAQ:VNDA) reported quarterly earnings of $0.16 per share. This is a 23.81 percent decrease over earnings of $0.21 per share from the same period last year. The company reported quarterly sales of $62.20 million which beat the analyst consensus estimate of $61.95 million by 0.40 percent. This is a 5.32 percent increase over sales of $59.06 million the same period last year.